These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 3969239)
1. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Richman CM; Holt JA; Lorincz MA; Herbst AL Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239 [TBL] [Abstract][Full Text] [Related]
2. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor. Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of estrogen and progestin receptors in ovarian cancer. Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas. Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]
7. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers? Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785 [TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Press MF; Holt JA; Herbst AL; Greene GL Lab Invest; 1985 Sep; 53(3):349-61. PubMed ID: 4033069 [TBL] [Abstract][Full Text] [Related]
9. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas. Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
12. Estrogen and progestin receptors in an ovarian ependymoma. Auerbach R; Mittal K; Schwartz PE Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1043-5. PubMed ID: 2836769 [TBL] [Abstract][Full Text] [Related]
13. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945 [TBL] [Abstract][Full Text] [Related]
14. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma. Jain V; Landry M; Levine EA Am Surg; 1996 Feb; 62(2):162-5. PubMed ID: 8554195 [TBL] [Abstract][Full Text] [Related]
15. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure. Goff BA; Ries JA; Els LP; Coltrera MD; Gown AM Gynecol Oncol; 1998 Sep; 70(3):378-85. PubMed ID: 9790791 [TBL] [Abstract][Full Text] [Related]
20. The role of estrogen receptor status in predicting the response of carcinoma of the breast to adjuvant chemotherapy. Stephens RB; Abeloff MD; Mellits ED; Baker RR Surg Gynecol Obstet; 1982 Feb; 154(2):200-4. PubMed ID: 6277024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]